Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Developmental toxicity / teratogenicity

Currently viewing:

Administrative data

Endpoint:
developmental toxicity
Type of information:
experimental study
Adequacy of study:
weight of evidence
Reliability:
4 (not assignable)

Data source

Referenceopen allclose all

Reference Type:
secondary source
Title:
Teratology study in rats. Compound FD&C Yellow No. 6.
Author:
International Research and Development Corporation
Year:
1972
Bibliographic source:
International Research and Development Corporation;Unpublished report no. 306-004 (1972)
Reference Type:
other: Authoritative data base
Title:
HSDB Number 4136
Author:
Hazardous Substances Data Bank
Year:
2011
Bibliographic source:
HSDB(Hazardous Substances Data Bank);US national Library of Medicine reviewed by SRC;WHO Food Additive Series 549: Sunset Yellow FCF (1964).
Reference Type:
other: Authoritative data base
Title:
GCID 181159
Author:
Aggregated Computational Toxicology Resource
Year:
2011
Bibliographic source:
ACToR(Aggregated Computational Toxicology Resource)[WHO Food Additive Series 549: Sunset Yellow FCF (1964).
Reference Type:
secondary source
Title:
International Research and Development Corporation (1972) Teratology study in rats. FD&C Yellow No. 6.
Author:
The International Association of Color Manufacturers/HPV Committee
Year:
2006
Bibliographic source:
Revised Robust Summaries for Sulfanilic acid (CAS No. 121 -57-3) and o-Toluene sulfonic acid, 4-amino-5-methoxy-(p-Cresidine sulfonic acid) (6471-78-9)

Materials and methods

Principles of method if other than guideline:
The developmental effects of FD&C Yellow No. 6 on Pregnant Charles River CD rats and their offspring by oral (gavage) route at different dose levels, on days 6-15 of gestation, were examined.
GLP compliance:
not specified

Test material

Constituent 1
Chemical structure
Reference substance name:
Disodium 6-hydroxy-5-[(4-sulphonatophenyl)azo]naphthalene-2-sulphonate
EC Number:
220-491-7
EC Name:
Disodium 6-hydroxy-5-[(4-sulphonatophenyl)azo]naphthalene-2-sulphonate
Cas Number:
2783-94-0
Molecular formula:
C16H12N2O7S2.2Na
IUPAC Name:
disodium 6-hydroxy-5-[(4-sulfonatophenyl)diazenyl]naphthalene-2-sulfonate
Details on test material:
- Name of test material: FD&C Yellow No. 6
- Molecular formula: C16H12N2O7S2.2Na
- Molecular weight: 454.38g/mole
- Substance type: organic
- Physical state: solid

Test animals

Species:
rat
Strain:
other: Charles River CD

Administration / exposure

Route of administration:
oral: gavage
Type of inhalation exposure (if applicable):
not specified
Vehicle:
other: methocel and retinoic acid
Details on exposure:
FD&C Yellow No. 6 was administered by gavage at dose levels of 100, 300 or 1000 mg/kg bw/day to 140 female Charles River CD rats. Three negative control groups (20/group) received the vehicle control while one control group received the positive control (7.5% mg/kg bw/day retinoic acid). All females were dosed on days 6-15 of gestation.
Analytical verification of doses or concentrations:
not specified
Duration of treatment / exposure:
9 days
Frequency of treatment:
Daily
Duration of test:
20 days
Doses / concentrations
Remarks:
Doses / Concentrations:
100, 300 or 1000 mg/kg/day
Basis:
no data
No. of animals per sex per dose:
140 female Charles River CD rats.
Negative control:Three groups of 20 rats/group
Positive control: one group of 20 rats
Control animals:
yes
Details on study design:
Three negative control groups were maintained and administered 0.5% methocel, while one positive control group was maintained and administered 7.5% mg/kg bw/day of retinoic acid.

Results and discussion

Results: maternal animals

Maternal developmental toxicity

Details on maternal toxic effects:
Maternal toxic effects:no effects

Details on maternal toxic effects:
No effect was observed on any other maternal parameters like body weight, corpora lutea, empty implantation sites, early resorptions, late resorptions, and live or dead term fetuses.

Effect levels (maternal animals)

Dose descriptor:
NOAEL
Effect level:
100 mg/kg bw/day
Based on:
test mat.
Basis for effect level:
other: no observed adverse effect

Results (fetuses)

Details on embryotoxic / teratogenic effects:
Embryotoxic / teratogenic effects:no effects

Details on embryotoxic / teratogenic effects:
No effect was observed on any fetal parameters evaluated like sex, external, internal and skeletal abnormalities. No teratogenicity was observed among the offspring.

Effect levels (fetuses)

open allclose all
Dose descriptor:
NOAEL
Effect level:
100 mg/kg bw/day
Based on:
test mat.
Basis for effect level:
other: teratogenicity
Dose descriptor:
LOAEL
Effect level:
300 mg/kg bw/day
Based on:
test mat.
Basis for effect level:
other: teratogenicity

Fetal abnormalities

Abnormalities:
not specified

Overall developmental toxicity

Developmental effects observed:
not specified

Applicant's summary and conclusion

Conclusions:
The teratogenicity of FD&C Yellow No. 6 was observed at dose concentrations of 0, 100, 300 or 1000 mg/kg bw/day, but no effect observed in parents and their offsprings at a dose concentration of 100 mg/kg bw/day. At a dose concentration of 300 mg/kg bw/day effects were observed as the mean weights of the offspring were decreased.
Therefore the ‘No observed adverse effect level (NOAEL) for teratogenicity was considered to be 100 mg/kg bw/day, and the “lowest observed adverse effect level (LOAEL)” was considered to be 300 mg/kg bw/day.
Executive summary:

The study was designed to investigate the teratogenic effects of FD&C Yellow No. 6 to pregnant rats by oral (gavage) route. FD&C Yellow No. 6 was administered by gavage at dose levels of 0,100, 300 or 1000 mg/kg bw/day to 140 female Charles River CD rats on days 6-15 of gestation.

 

No compound related effectswere observedon early or late resorptions, empty implantation sites, body weight or numbers of live or dead fetuses. No teratogenicity was observed among the offspring at concentration 100 mg/kg bw/day.

 

The mean weights of the offspring from the 300 and 1000 mg/kg bw/day groups were decreased when compared to the average fetus weight of the combined negative controls.

 

Therefore the ‘No observed adverse effect level (NOAEL) for teratogenicity was considered to be 100 mg/kg bw/day,andthe“lowest observed adverse effect level (LOAEL)” was considered to be 300 mg/kg bw/day when administered orally.